Abstract
The ability to alter the mouse genome through homologous recombination in their embryonic stem (ES) cells, and propagate the modification through their germ-line, has revolutionized biomedical research. Such gene-targeted mice have afforded researchers unprecedented opportunities to analyze gene function in vivo, and provided models for disease studies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Evans, M. J., and Kaufman, M. H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154–156.
Martin, G. R. (1981) Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. USA 78, 7634–7638.
Bradley, A., Evans, M., Kaufman, M. H., and Robertson, E. (1984) Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255–256.
Smithies, O., Gregg, R. G., Boggs, S. S., Koralewski, M. A., and Kucherlapati, R. S. (1985) Insertion of DNA sequences into the human chromosomal beta-globin locus by homologous recombination. Nature 317, 230–234.
Thomas, K. R., and Capecchi, M. R. (1987) Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503–512.
Doetschman, T., Maeda, N., and Smithies, O. (1988) Targeted mutation of the Hprt gene in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 85, 8583–8587.
Koller, B. H., Hagemann, L. J., Doetschman, T., et al. (1989) Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc. Natl. Acad. Sci. USA 86, 8927–8931.
Schwartzberg, P. L., Goff, S. P., and Robertson, E. J. (1989) Germ-line transmission of a c-abl mutation produced by targeted gene disruption in ES cells. Science 246, 799–803.
Thompson, L. H., and Schild, D. (1999) The contribution of homologous recombination in preserving genome integrity in mammalian cells. Biochimie 81, 87–105.
Hasty, P., Rivera-Perez, J., Chang, C., and Bradley, A. (1991) Target frequency and integration pattern for insertion and replacement vectors in embryonic stem cells. Mol. Cell Biol. 11, 4509–4517.
Mansour, S. L., Thomas, K. R., and Capecchi, M. R. (1988) Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348–352.
Hasty, P., Abuin, A., and Bradley, A. (2000) Gene targeting, principles, and practice in mammalian cells. In Gene Targeting—A Practical Approach. 2 ed. Joyner, A. L., ed. Oxford University Press, New York, NY, pp. 1–35.
Lurquin, P. F. (1997) Gene transfer by electroporation. Mol. Biotechnol. 7, 5–35.
Andreason, G. L., and Evans, G. A. (1989) Optimization of electroporation for transfection of mammalian cell lines. Anal. Biochem. 180, 269–275.
Lupton, S. D., Brunton, L. L., Kalberg, V. A., and Overell, R. W. (1991) Dominant positive and negative selection using a hygromycin phosphotransferase-thymidine kinase fusion gene. Mol. Cell Biol. 11, 3374–3378.
Chen, Y T., and Bradley, A. (2000) A new positive/negative selectable marker, puDeltatk, for use in embryonic stem cells. Genesis 28, 31–35.
Karreman, C. (1998) New positive/negative selectable markers for mammalian cells on the basis of Blasticidin deaminase-thymidine kinase fusions. Nucleic Acids Res. 26, 2508–2510.
Selfridge, J., Pow, A. M., McWhir, J., Magin, T. M., and Melton, D. W. (1992) Gene targeting using a mouse HPRT minigene/HPRT-deficient embryonic stem cell system: inactivation of the mouse ERCC-1 gene. Somat. Cell Mol. Genet. 18, 325–336.
Vasquez, K. M., Marburger, K., Intody, Z., and Wilson, J. H. (2001) Manipulating the mammalian genome by homologous recombination. Proc. Natl. Acad. Sci. USA 98, 8403–8410.
Yagi, T., Ikawa, Y., Yoshida, K., et al. (1990) Homologous recombination at c-fyn locus of mouse embryonic stem cells with use of diphtheria toxin A-fragment gene in negative selection. Proc. Natl. Acad. Sci. USA 87, 9918–9922.
Kobayashi, K., Ohye, T., Pastan, I., and Nagatsu, T. (1996) A novel strategy for the negative selection in mouse embryonic stem cells operated with immunotoxin-mediated cell targeting. Nucleic Acids Res. 24, 3653–3655.
Donehower, L. A., Harvey, M., Slagle, B. L., et al. (1992) Mice deficient for p53 are devel-opmentally normal but susceptible to spontaneous tumours. Nature 356, 215–221.
Lindberg, R. L., Porcher, C., Grandchamp, B., et al. (1996) Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria. Nat. Genet. 12, 195–199.
te Riele, H., Maandag, E. R., and Berns, A. (1992) Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. Natl. Acad. Sci. USA 89, 5128–5132.
Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A., and Seidman, J. G. (1992) Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell Biol. 12, 2391–2395.
Mortensen, R. M., Zubiaur, M., Neer, E. J., and Seidman, J. G (1991) Embryonic stem cells lacking a functional inhibitory G-protein subunit (alpha i2) produced by gene targeting of both alleles. Proc. Natl. Acad. Sci. USA 88, 7036–7040.
te Riele, H., Maandag, E. R., Clarke, A., Hooper, M., and Berns, A. (1990) Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature 348, 649–651.
Utomo, A. R., Nikitin, A. Y., and Lee, W. H. (1999) Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nat. Biotechnol. 17, 1091–1096.
Sauer, B. (1998) Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381–392.
Torres, R. M., and Kuhn, R., eds. (1997) Laboratory protocols for conditional gene targeting. Oxford University Press, Oxford, UK.
Rajewsky, K., Gu, H., Kuhn, R., et al. (1996) Conditional gene targeting. J. Clin. Invest. 98, 600–603.
Wilson, T. J., and Kola, I. (2001) The LoxP/CRE system and genome modification. Methods Mol. Biol. 158, 83–94.
Le, Y, and Sauer, B. (2000) Conditional gene knockout using cre recombinase. Methods Mol. Biol. 136, 477–485.
Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766–1769.
No, D., Yao, T P., and Evans, R. M. (1996) Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc. Natl. Acad. Sci. USA 93, 3346–3351.
Danielian, P. S., Muccino, D., Rowitch, D. H., Michael, S. K., and McMahon, A. P. (1998) Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 8, 1323–1326.
Hayashi, S., and McMahon, A. P. (2002) Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev. Biol. 244, 305–318.
Dietrich, P., Dragatsis, I., Xuan, S., Zeitlin, S., and Efstratiadis, A. (2000) Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm. Genome 11, 196–205.
Gannon, M., Shiota, C., Postic, C., Wright, C. V., and Magnuson, M. (2000) Analysis of the Cre-mediated recombination driven by rat insulin promoter in embryonic and adult mouse pancreas. Genesis 26, 139–142.
Rossant, J., and McMahon, A. (1999) “Cre”-ating mouse mutants-a meeting review on conditional mouse genetics. Genes Dev. 13, 142–145.
Fiering, S., Epner, E., Robinson, K., et al. (1995) Targeted deletion of 5′HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev. 9, 2203–2213.
Valancius, V., and Smithies, O. (1991) Testing an “in-out” targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol. Cell Biol. 11, 1402–1408.
Hasty, P., Ramirez-Solis, R., Krumlauf, R., and Bradley, A. (1991) Introduction of a subtle mutation into the Hox-2.6 locus in embryonic stem cells. Nature 350, 243–246.
Askew, G. R., Doetschman, T., and Lingrel, J. B. (1993) Site-directed point mutations in embryonic stem cells: a gene-targeting tag-and-exchange strategy. Mol. Cell Biol. 13, 4115–4124.
Reid, L. H., Shesely, E. G., Kim, H. S., and Smithies, O. (1991) Cotransformation and gene targeting in mouse embryonic stem cells. Mol. Cell Biol. 11, 2769–2677.
Davis, A. C., Wims, M., and Bradley, A. (1992) Investigation of coelectroporation as a method for introducing small mutations into embryonic stem cells. Mol. Cell Biol. 12, 2769–2776.
Sambrook, J., Fritsch, E. F., and Maniatis, T (1989) Molecular Cloning—A Laboratory Manual. 2ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., and Roder, J. C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. USA 90, 8424–8428.
Smith, A. G., and Hooper, M. L. (1987) Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev. Biol. 121, 1–9.
Williams, R. L., Hilton, D. J., Pease, S., et al. (1988) Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336, 684–687.
Wood, S. A., Allen, N. D., Rossant, J., Auerbach, A., and Nagy, A. (1993) Non-injection methods for the production of embryonic stem cell-embryo chimaeras. Nature 365, 87–89.
Kawase, E., Suemori, H., Takahashi, N., Okazaki, K., Hashimoto, K., and Nakatsuji, N. (1994) Strain difference in establishment of mouse embryonic stem (ES) cell lines. Int. J. Dev. Biol. 38, 385–390.
Doetschman, T., Gregg, R. G., Maeda, N., et al. (1987) Targeted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 330, 576–578.
Doetschman, T C., Eistetter, H., Katz, M., Schmidt, W., and Kemler, R. (1985) The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87, 27–45.
Soriano, P., Montgomery, C., Geske, R., and Bradley, A. (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693–702.
Auerbach, W., Dunmore, J. H., Fairchild-Huntress, V., et al. (2000) Establishment and chimera analysis of 129/SvEv-and C57BL/6-derived mouse embryonic stem cell lines. Biotechniques 29, 1024–1028, 1030, 1032.
Ledermann, B., and Burki, K. (1991) Establishment of a germ-line competent C57BL/6 embryonic stem cell line. Exp. Cell Res. 197, 254–258.
Noben-Trauth, N., Kohler, G., Burki, K., and Ledermann, B. (1996) Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line. Transgenic Res. 5, 487–491.
Dinkel, A., Aicher, W.K., Warnatz, K., Burki, K., Eibel, H., and Ledermann, B. (1999) Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells. J. Immunol. Methods 223, 255–260.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Rozmahel, R. (2003). Mouse Genome Modification. In: Nag, S. (eds) The Blood-Brain Barrier. Methods in Molecular Medicine™, vol 89. Humana Press. https://doi.org/10.1385/1-59259-419-0:529
Download citation
DOI: https://doi.org/10.1385/1-59259-419-0:529
Publisher Name: Humana Press
Print ISBN: 978-1-58829-073-1
Online ISBN: 978-1-59259-419-1
eBook Packages: Springer Protocols